Novo Medi Sciences Launches Next-Generation Varicella Vaccine NEXIPOX PLUS®
Novo Medi Sciences Pvt. Ltd. has announced the launch of NEXIPOX PLUS®, a next-generation varicella (chickenpox) vaccine, developed using an […]
Novo Medi Sciences Pvt. Ltd. has announced the launch of NEXIPOX PLUS®, a next-generation varicella (chickenpox) vaccine, developed using an […]
Naprod Life Sciences has secured the renewal of its ANVISA Good Manufacturing Practice (GMP) certification for its manufacturing facility located […]
Sarepta Therapeutics has reported three-year data showing slowed disease progression for its gene therapy Elevidys in patients with Duchenne muscular […]
India’s active pharmaceutical ingredient (API) manufacturers have urged the government to introduce import curbs and support for GMP upgrades in […]
Janux Therapeutics has entered into a collaboration and licensing agreement with Bristol Myers Squibb (BMS) valued at up to USD […]
GSK has agreed to acquire Rapt Therapeutics in a transaction valued at approximately USD 2.2 billion, securing rights to the […]
Qure.ai has received a multimillion-dollar global health grant from the Gates Foundation to develop AI-powered point-of-care ultrasound solutions aimed at […]
Novavax has entered into a licensing agreement with Pfizer that allows the global pharmaceutical major to use Novavax’s Matrix-M adjuvant […]
Rainbow Children’s Medicare Limited has appointed Abrarali Dalal as its Chief Executive Officer, effective January 20, 2026, as part of […]
Narayana Hrudayalaya Limited has incorporated a wholly owned subsidiary, Narayana Healthcare North Private Limited, to strengthen its healthcare operations in […]
Novo Nordisk has expanded its collaboration with Aspect Biosystems to accelerate the development of cell-based therapies for diabetes, strengthening a […]
Pfizer will exit ViiV Healthcare through a transaction valued at approximately USD 1.9 billion, leading to a major change in […]
As the Union Budget 2026 approaches, the pharmaceutical industry is seeking policy measures focused on customs duty rationalisation, increased R&D […]